Certolizumab-pegol/infliximabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1956卷 / 1期

关键词：

D O I：

10.1007/s40278-023-38752-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：139 / 139

相关论文

共 50 条

[1] Certolizumab-pegol/methotrexateLiver injury: case report
Reactions Weekly, 2023, 1982 (1) : 123 - 123
[2] Adalimumab/certolizumab-pegol/sulfasalazineRenal sarcoidosis and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 25 - 25
[3] Adalimumab/certolizumab-pegol/infliximabPsoriasis : case report
Reactions Weekly, 2016, 1595 (1) : 15 - 15
[4] Adalimumab/Certolizumab-pegol/MethotrexateMiliary histoplasmosis: case report
Reactions Weekly, 2024, 2028 (1) : 23 - 23
[5] Certolizumab-pegol/methotrexate/tocilizumabLack of efficacy and urticarial drug eruption: case report
Reactions Weekly, 2022, 1931 (1) : 177 - 177
[6] Corticosteroids/certolizumab-pegol/ustekinumabLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1963 (1) : 177 - 177
[7] Certolizumab-pegol/mycophenolate-mofetil/prednisoloneImmunoglobulin A vasculitis and lack of efficacy: case report
Reactions Weekly, 2025, 2052 (1) : 121 - 121
[8] Certolizumab-pegol/infliximab/prednisonePulmonary embolism with pulmonary infarction and lack of efficacy : case report
Reactions Weekly, 2022, 1912 (1) : 146 - 146
[9] Certolizumab-pegol/leflunomide/methotrexateAccelerated pulmonary nodulosis: case report
Reactions Weekly, 2025, 2044 (1) : 92 - 92
[10] Certolizumab-pegol/methotrexateFirst report of severe glandular tularemia: case report
Reactions Weekly, 2017, 1658 (1) : 118 - 118

← 1 2 3 4 5 →